TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
36.50
-0.26 (-0.71%)
At close: Oct 7, 2025, 4:00 PM EDT
36.61
+0.11 (0.30%)
After-hours: Oct 7, 2025, 7:47 PM EDT

TG Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover TG Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $47.5, which forecasts a 30.14% increase in the stock price over the next year. The lowest target is $22 and the highest is $60.

Price Target: $47.5 (+30.14%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$22$47.5$55$60
Change-39.73%+30.14%+50.68%+64.38%

Analyst Ratings

The average analyst rating for TG Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy444434
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total666656

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$60
Strong BuyInitiates$60+64.38%Oct 6, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$53$55
Strong BuyMaintains$53$55+50.68%Sep 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$55
Strong BuyReiterates$55+50.68%Mar 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$55
Strong BuyReiterates$55+50.68%Jan 15, 2025
JP Morgan
JP Morgan
Buy
Maintains
$30$43
BuyMaintains$30$43+17.81%Nov 25, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
599.52M
from 329.00M
Increased by 82.22%
Revenue Next Year
885.85M
from 599.52M
Increased by 47.76%
EPS This Year
0.79
from 0.15
Increased by 428.14%
EPS Next Year
1.94
from 0.79
Increased by 145.06%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
152.00K6.69M2.79M233.66M329.00M599.52M885.85M
Revenue Growth
-4,300.66%-58.36%8,290.02%40.80%82.22%47.76%
EPS
-2.42-2.63-1.650.090.150.791.94
EPS Growth
----68.04%428.14%145.06%
Forward PE
-----46.0718.80
No. Analysts
-----1010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High621.4M973.4M
Avg599.5M885.9M
Low571.1M820.3M

Revenue Growth

Revenue Growth20252026202720282029
High
88.9%
62.4%
Avg
82.2%
47.8%
Low
73.6%
36.8%

EPS Forecast

EPS20252026202720282029
High1.012.61
Avg0.791.94
Low0.521.32

EPS Growth

EPS Growth20252026202720282029
High
572.0%
230.0%
Avg
428.1%
145.1%
Low
246.3%
67.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.